Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis.

Helen R Savage Victor Santana Santos Thomas Edwards Emanuele Giorgi Sanjeev Krishna Timothy D Planche Henry M StainesJoseph R A FitchettDaniela E Kirwan Ana Isabel Cubas-Atienzar David J ClarkEmily R AdamsLuis Eduardo Cuevas

Published in: PLoS neglected tropical diseases (2021)

85% of individuals with proven SARS-CoV-2 infection had detectable neutralising antibodies. This proportion varied with disease severity, study setting, time since infection and the method used to measure antibodies.

Keyphrases

sars cov
respiratory syndrome coronavirus
liver failure
risk factors
coronavirus disease
hepatitis b virus